Published in Acta Psychiatr Scand Suppl on January 01, 1974
A comprehensive psychopathological rating scale. Acta Psychiatr Scand Suppl (1978) 2.50
Attitudes to reporting adverse drug reactions in northern Sweden. Eur J Clin Pharmacol (2000) 1.72
Under-reporting of serious adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf (2004) 1.72
HMG-CoA reductase inhibitors and myotoxicity. Drug Saf (2000) 1.51
Ectopic synthesis of pregnancy specific beta 1-glycoprotein (SP1) and placental specific tissue proteins (PP5, PP10, PP11, PP12) in nontrophoblastic malignant tumours. Possible markers in oncology. Klin Wochenschr (1980) 1.51
Development of a new inventory assessing memories of parental rearing behaviour. Acta Psychiatr Scand (1980) 1.41
Human brain contains high levels of heteroplasmy in the noncoding regions of mitochondrial DNA. Proc Natl Acad Sci U S A (1996) 1.38
Platelet serotonin 5-HT2A receptor binding in patients with carcinoid tumor. Scand J Clin Lab Invest (2004) 1.37
Evaluation of a computer-based decision support system for treatment of hypertension with drugs: retrospective, nonintervention testing of cost and guideline adherence. J Intern Med (2000) 1.21
Investigation of the functional effect of monoamine oxidase polymorphisms in human brain. Hum Genet (2001) 1.20
A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. J Psychiatr Res (2000) 1.19
Environmental factors and drug trials. 1. Staff attitudes to drug trials at psychiatric hospitals. Acta Psychiatr Scand Suppl (1974) 1.15
Markers for vulnerability to psychopathology: temperament traits associated with platelet MAO activity. Acta Psychiatr Scand (1987) 1.13
Platelet MAO activity as a biological marker in subgroups of alcoholism. Acta Psychiatr Scand (1985) 1.13
Does Swedish amateur boxing lead to chronic brain damage? 1. A retrospective medical, neurological and personality trait study. Acta Neurol Scand (1990) 1.13
Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications. J Clin Psychiatry (1998) 1.10
Immunohistochemical studies on human gastric mucosa. Procedures for routine demonstration of gastric proteins by immunoenzyme techniques. Virchows Arch A Pathol Anat Histol (1978) 1.09
The effect of age on the activity and molecular properties of human brain monoamine oxidase. J Neural Transm (1980) 1.08
Human fear conditioning is related to dopaminergic and serotonergic biological markers. Behav Neurosci (2001) 1.08
Repeated episodes of hypothermia in a subject treated with haloperidol, levomepromazine, olanzapine, and thioridazine. J Clin Psychopharmacol (2001) 1.08
Alcoholics with reduced dopamine D2 receptor function possess normal platelet monoamine oxidase activity. Alcohol Alcohol (1994) 1.07
Personality traits and platelet MAO activity in alcohol and drug abusing teenage boys. Acta Psychiatr Scand (1987) 1.07
Maltreatment, MAOA, and delinquency: sex differences in gene-environment interaction in a large population-based cohort of adolescents. Behav Genet (2010) 1.06
The course and outcome of cycloid psychosis. Psychol Med (1982) 1.05
[Agarose gel electrophoresis of lipoproteins]. Clin Chim Acta (1968) 1.04
Adverse drug reaction reporting by nurses in Sweden. Eur J Clin Pharmacol (2007) 1.03
Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus. Brain Res Brain Res Rev (2001) 1.02
[Methods for the quantitative determination of plasma proteins by immunoprecipitation]. Z Klin Chem Klin Biochem (1968) 1.00
[On the nosology of endogenous depression. Comparison of the results of two studies]. Arch Psychiatr Nervenkr (1970) (1968) 1.00
Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study. J Psychiatr Res (1986) 0.99
Spontaneous reporting of adverse drug reactions by nurses. Pharmacoepidemiol Drug Saf (2002) 0.98
Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics. Genomics (1995) 0.98
Carbamazepine markedly reduces serum concentrations of simvastatin and simvastatin acid. Eur J Clin Pharmacol (2003) 0.98
[Explicit communication is desirable in psychoanalysis]. Lakartidningen (1993) 0.97
Monoamine oxidase-B in astrocytes. Glia (1993) 0.97
Purification and properties of pig liver mitochondrial monoamine oxidase. Arch Biochem Biophys (1971) 0.97
Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism. Adv Biochem Psychopharmacol (1980) 0.97
Changes in uptake of vitamin B(12) and trace metals in brains of mice treated with clioquinol. J Neurol Sci (2000) 0.96
A small economic inducement to stimulate increased reporting of adverse drug reactions--a way of dealing with an old problem? Eur J Clin Pharmacol (2006) 0.95
[Autoantibodies in cancer patients]. Presse Med (1965) 0.94
Mitochondrial enzyme deficiencies in Down's syndrome. J Neural Transm Park Dis Dement Sect (1994) 0.94
A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. X. Mortality, suicide and life-cycles. Acta Psychiatr Scand Suppl (1966) 0.92
Abnormality on paternal and maternal sides: observations in bipolar (manic-depressive) and unipolar depressive psychoses. Br J Psychiatry (1971) 0.91
Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT). Neurobiol Aging (1983) 0.91
Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci (1980) 0.91
Orthotic devices in functional treatment of ankle sprain. Stabilizing effects during real movements. Int J Sports Med (1993) 0.90
Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in Type 2 diabetes mellitus complicated by retinopathy. Diabet Med (1999) 0.90
IBM's Health Analytics and Clinical Decision Support. Yearb Med Inform (2014) 0.90
Adrenaline, emotional arousal and memory. Scand J Psychol (1985) 0.89
A controlled trial of pimozide and trifluoperazine in chronic schizophrenic syndromes. Acta Psychiatr Scand Suppl (1974) 0.89
Cycloid psychoses: diagnosis and heuristic value. J Nerv Ment Dis (1982) 0.89
Fourth generation languages. Comput Healthc (1985) 0.89
A study of cycloid psychoses. Acta Psychiatr Scand Suppl (1974) 0.88
Low platelet monoamine oxidase activity in cigarette smokers. Life Sci (1981) 0.88
A new hybrid resin for stepwise screening of peptide libraries combined with single bead Edman sequencing. J Pept Sci (1998) 0.88
A histochemical demonstration of altered cytochrome oxidase activity in the rat brain by neuroleptics. Eur Neuropsychopharmacol (1998) 0.87
Neuroleptic-induced mitochondrial enzyme alterations in the rat brain. J Pharmacol Exp Ther (1997) 0.87
Low platelet monoamine oxidase activity in human alcoholics. Med Biol (1977) 0.87
Methodological aspects for in vitro characterization of receptor binding using 11C-labeled receptor ligands: a detailed study with the benzodiazepine receptor antagonist [11C]Ro 15-1788. Nucl Med Biol (1997) 0.87
Parental loss by death in the early childhood of depressed patients and of their healthy siblings. Br J Psychiatry (1986) 0.87
Leptin concentrations are increased in subjects treated with clozapine or conventional antipsychotics. J Clin Psychiatry (2001) 0.87
[Differentiated quantitative serum protein determination during myocardial infarct]. Schweiz Med Wochenschr (1968) 0.87
Genetic mechanisms of behavior--don't forget about the transcription factors. Mol Psychiatry (2001) 0.87
Serotonin syndrome caused by a moclobemide-clomipramine interaction. BMJ (1993) 0.86
Chronic mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical effects of DSP-4 treatment. Eur Neuropsychopharmacol (1999) 0.86
Monoamine oxidase activity and localisation in the brain and the activity in relation to psychiatric disorders. Mod Probl Pharmacopsychiatry (1983) 0.86
Monoamine oxidase B in brains from patients with Alzheimer's disease: a biochemical and autoradiographical study. Neuroscience (1991) 0.85
Substrate- and stereoselective inhibitor of human brain monoamine oxidase by 4-dimethylamino-alpha, 2-dimethylphenethylamine (FLA 336). J Pharm Pharmacol (1981) 0.85
The effect of deprenyl (selegiline) on intra- and extraneuronal dopamine oxidation. Acta Neurol Scand Suppl (1983) 0.85
Dose-dependent effects of noradrenergic denervation by DSP-4 treatment on forced swimming and beta-adrenoceptor binding in the rat. J Neural Transm (Vienna) (1999) 0.85
Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls. Psychiatry Res (1981) 0.85
Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistry. Brain Res (2001) 0.85
Lesioning of locus coeruleus projections by DSP-4 neurotoxin treatment: effect on amphetamine-induced hyperlocomotion and dopamine D2 receptor binding in rats. Pharmacol Toxicol (2000) 0.85
Morbidity risk for psychiatric disorders in families of probands with affective disorders divided according to levels of platelet MAO activity. Psychiatry Res (1985) 0.85
[Antigens and enzymes in subcellular fractions of human fundic mucosa. Immunoelectrophoretic and electrophoretic studies in agar gel]. Z Gesamte Exp Med (1969) 0.85
Thrombocyte monoamine oxidase activity and personality traits in women with severe premenstrual syndrome. Acta Psychiatr Scand (1987) 0.85
Levels of L-methionine S-adenosyltransferase activity in erythrocytes and concentrations of S-adenosylmethionine and S-adenosylhomocysteine in whole blood of patients with Parkinson's disease. Exp Neurol (1997) 0.84
Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics. Neuropsychopharmacology (2000) 0.84
Immunization and affinity purification of antibodies using resin-immobilized lysine-branched synthetic peptides. Pept Res (1994) 0.84
Chronic citalopram treatment induces time-dependent changes in the expression and DNA-binding activity of transcription factor AP-2 in rat brain. Eur Neuropsychopharmacol (2003) 0.84
The development of mental state attributions in women with X-monosomy, and the role of monoamine oxidase B in the sociocognitive phenotype. Cognition (2006) 0.84
Quantitative localization of human brain monoamine oxidase B by large section autoradiography using L-[3H]deprenyl. Brain Res (1991) 0.84
Studies on semicarbazide-sensitive amine oxidase in patients with diabetes mellitus and in transgenic mice. Biochim Biophys Acta (2003) 0.84
Levels of transcription factors AP-2alpha and AP-2beta in the brainstem are correlated to monoamine turnover in the rat forebrain. Neurosci Lett (2001) 0.83
A polymorphic region in the human transcription factor AP-2beta gene is associated with specific personality traits. Mol Psychiatry (2000) 0.83
Effect of lipid-depletion on the different forms of monoamine oxidase in rat liver mitochondria. Biochem Pharmacol (1976) 0.83
Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics. Neuropsychopharmacology (1999) 0.83
A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. I. Genetic investigation. Acta Psychiatr Scand Suppl (1966) 0.83
Lowered monoamine oxidase activity in brains from alcoholic suicides. J Neurochem (1975) 0.83
Decreased density of serotonin 5-HT2A receptors in rheumatoid arthritis. Ann Rheum Dis (2006) 0.83
Autoradiographic imaging of formaldehyde adducts in mice: possible relevance for vascular damage in diabetes. Life Sci (1998) 0.83
Platelet monoamine oxidase activity is related to MAOB intron 13 genotype. J Neural Transm (Vienna) (2000) 0.83
MPTP toxicity in relation to age, dopamine uptake and MAO-B activity in two rodent species. Pharmacol Toxicol (1989) 0.83
Brain and brain monoamine oxidase in aging and in dementia of Alzheimer's type. Prog Neuropsychopharmacol Biol Psychiatry (1986) 0.83
Effect of reserpine on the brain uptake of carbon 11 methamphetamine and its N-propagyl derivative, deprenyl. Eur J Nucl Med (1990) 0.83
A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. Introduction. Acta Psychiatr Scand Suppl (1966) 0.83
Purification of human intestinal goblet cell antigen (GOA), its immunohistological demonstration in the intestine and in mucus producing gastrointestinal adenocarcinomas. Virchows Arch A Pathol Anat Histol (1979) 0.83